Ascorbic acid and α-tocopherol attenuate methylmalonic acid-induced convulsions

NeuroReport

Volumn 10, Issue 10, 1999, Pages 2039-2043

  Fighera, Michele Rechia ^c   Queiroz, Cláudio Marcos ^a   Stracke, Marcelo Paulo ^c   Brauer, Martin Cláudio Nin ^c   González Rodríguez, Larissa Linnette ^c   Frussa Filho, Roberto ^a   Wajner, Moacir ^b   De Mello, Carlos Fernando ^c  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

Author keywords

Antioxidants; Ascorbic acid; Convulsion; Excitotoxicity; Glutamate; Melatonin; Methylmalonic acid; Succinate dehydrogenase; Tocopherol

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; MELATONIN; METHYLMALONIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; CONVULSION; EPILEPTOGENESIS; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NEUROMODULATION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0033551603     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199907130-00009     Document Type: Article

References (29)

1. Fenton WA and Rosenberg LE. Disorders of propionate and methylmalonate metabolism. In: Scriver CR, Beaudet AL, Sly WS and Valle D, eds. The Metabolic Basis of Inherited Disease. New York; McGraw-Hill, 1995: 1423-1449.
2. Dutra JC, Wajner M, Wannmacher CMD et al. J Inher Metab Dis 16, 147-153 (1993).
3. Mello CF, Begnini J, Jimėnez-Bernal RE et al. Brain Res 721, 120-125 (1996).
4. Mello CF, Rubin MA, Coelho J et al. Biochem Mol Biol Int 42, 1143-1150 (1997).
5. McLaughling BA, Nelson D, Silver IA et al. Neuroscience 86, 279-290 (1998).
6. Greenamyre JT, Garcia-Osuna M and Greene JG. Neurosci Lett 171, 17-20 (1994).
7. Beal MF, Henshaw DR, Jenkins BG et al. Ann Neurol 36, 882-888 (1994).
8. Beal MF, Ferrante RJ, Henshaw R et al. J Neurochem 65, 919-922 (1995).
9. Schulz JB, Henshaw DR, Siwek D et al. J Neurochem 64, 2239-2247 (1995).
10. Schulz JB, Matthews RT, Jenkins BG et al. J Neurosci 15, 8419-8429 (1995).
11. Schulz JB, Henshaw DR, Matthews RT and Beal MF. Exp Neurol 132, 279-283 (1995).
12. Schulz JB, Huang PL, Matthews RT et al. J Neurochem 67, 430-433 (1996).
13. Murashima YL, Kasamo K and Suzuki J. Epilepsy Res 32, 254-65 (1998).
14. Hiramatsu M, Nakajima M, Komatsu M et al. Electron spin resonance-computed tomography. Brain imaging and epilepsy. In Packer L, Hiramatsu M and Yoshikawa T, eds. Free Radicals in Brain Physiology and Disorders. San Diego, Academic Press, 1996: 185-195.
15. Sun AY, Cheng Y, Bu Q and Oldfield F. Mol Chem Neuropathol 17, 51-63 (1992).
16. MacGregor DG, Higgins MJ, Ogilvy HV et al. Biochem Soc Trans 22, 17S (1993).
17. Kim YS, Joo WS, Jin BK et al. NeuroReport 9, 2387-2390 (1998).
18. Namiki M. Crit Rev Food Sci Nutr 29, 273-300 (1990).
19. Sparapani M. DallOlio R, Gandolfi O et al. Exp Neurol 148, 157-166 (1997).
20. Hall ED, Yonkers PA, Andrus PK et al. J Neurotrauma 9, S425-S442 (1992).
21. Lan J and Jiang DH. J Neural Transm 104, 469-481 (1997).
22. Grūnewald RA. Brain Res Rev 18, 123-133 (1993).
23. Tan DX, Chan LD, Poeggeler B et al. Endocr J 1, 57-60 (1993).
24. Harderland RJ, Reiter RJ, Poeggeler B and Tan DX. Neurosci Biobehav Rev 17, 347-357 (1993).
25. Stantov B, Fraschini F and Reiter RJ. Brain Res Rev 16, 245-256 (1991).
26. Giusti P, Gusella M, Lipartiti M et al. Exp Neurol 131, 39-46 (1995).
27. Tenn CC and Niles LP. Neuropharmacology 36, 1659-1663 (1997).
28. Zeevalk GD, Derr-Yellin E and Nicklas WJ. J Neurochem 64, 455-458 (1995).
29. Kim YS and Kwon D. Arch Pharm Res 22, 35-43 (1999).